EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
In Depth
News image
On Air
News image
Archive
News image
News image
News image
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageTuesday, June 1, 1999 Published at 16:15 GMT 17:15 UK
News image
News image
Health
News image
Obesity drug does keep you slim
News image
Xenical can help people stay slim
News image
Orlistat, a drug that has been hailed as Viagra for the obese, has been given the thumbs up by researchers who carried out the the first long-term study into its effect.

The drug was shown to help successful dieters keep weight off in a study published in the American Journal of Clinical Nutrition.

After losing eight per cent of their body weight over six months without the help of the drug, patients taking orlistat regained only around half the weight in the following six months compared to those carrying on without it.

In addition, the orlistat group showed a greater reduction in cholesterol than those not taking the drug.

However, AJCN Editor-in-Chief Charles Halstead said the results did not herald the arrival of a solution for obesity.

He wrote: "One must question why, after one year of treatment, three fourths of patients had begun the relentless process of weight regain."

Orlistat is marketed in the UK as Xenical. Manufacturers Roche Products believe it could be suitable for more than 15% of the UK population.

The drug works by blocking the absorption of fat in the gut and should be taken as part of a low-fat diet.

If people taking it eat a fatty diet, they experience a bloated and painful stomach and oily diarrhoea.

Patients given Xenical have been shown to lose an average of 10% in body weight over a year, compared with a 6% loss for those who only follow a low-fat diet.

Resource fears


[ image: More than 15 per cent of people could be suitable for the drug]
More than 15 per cent of people could be suitable for the drug
The Royal College of Physicians issued tough guidance on the prescription of obesity drugs earlier this year.

Under RCP guidelines overweight patients will only be prescribed drugs such as Xenical as a last resort if diet and exercise changes have failed..

The guidelines stipulate that treatment should be stopped if the patient does not lose 5% of their weight within three months.

The guidance followed concerns that huge demand for Xenical would drain NHS resources.

Conversely, some doctors were also concerned that health authorities tended to view obesity as a self-inflicted problem and were reluctant to pay for its treatment.

The Obesity Resource Information Centre (ORIC) has warned that some patients lose more weight than others on Xenical.

The ORIC stressed that Xenical is not a miracle cure and should only be used as part of a weight management programme.

Obese people are defined as those whose weight in kilos divided by their height in metres squared is over 30. This measurement is known as the Body Mass Index.

Xenical is likely to be available to people with a BMI of over 28, provided they have other associated risk factors such as diabetes.

News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageNews image
Relevant Stories
News image
27 May 99�|�Health
Task force takes on obesity
News image
19 Apr 99�|�Health
Obesity rise 'founded on denial'
News image
13 Jan 99�|�Health
Tough guidance on obesity drugs
News image
13 Jan 99�|�Health
Fat hope for an obesity cure
News image
21 Sep 98�|�Health
Fears of stampede over fat-busting drug
News image
31 Jul 98�|�Health
Pill gets go-ahead for battle of the bulge
News image

News image
News image
News image
News imageInternet Links
News image
News imageNews image
American Journal of Clinical Nutrition
News image
Orlistat
News image
Obesity
News image
Obesity and weight control
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image